Remove Bioavailability Remove Compliance Remove In-Vivo
article thumbnail

The Composition and Value of a Portfolio Analysis

Camargo

Clinical pharmacology may also involve comparative bioavailability analyses, which are generally required for drug formulation bridging studies, to demonstrate bioequivalence. These are put in place to ensure product quality in compliance with FDA requirements. Clinical Pharmacology. Clinical Safety and Efficacy.

article thumbnail

Advancing from Research to Development: What Can Go Wrong?

Camargo

Nonclinical programs include (but are not limited to) method development and validation, pharmacokinetic studies, in vivo efficacy studies, safety pharmacology, IND-enabling toxicology studies, and long-term studies when appropriate. Overview of Drug Development Programs (Through IND Submission). Expensive starting materials.